Potable water and Mycobacterium avium complex in HIV patients: is prevention possible?

The Lancet ◽  
1994 ◽  
Vol 343 (8906) ◽  
pp. 1110-1111 ◽  
Author(s):  
Nina Singh ◽  
VictorL. Yu
Keyword(s):  
Mycobacterium Avium ◽  
Mycobacterium Avium Complex ◽  
Potable Water ◽  
Hiv Patients

Colonisation of potable water with Mycobacterium avium complex in homes of HIV-infected patients

The Lancet ◽  
1994 ◽  
Vol 343 (8913) ◽  
pp. 1639 ◽  
Author(s):  
MarisaA. Montecalvo ◽  
Gilda Forester ◽  
AnnaY. Tsang ◽  
Gary du Moulin ◽  
GaryP. Wormser
Keyword(s):  
Mycobacterium Avium ◽  
Mycobacterium Avium Complex ◽  
Potable Water

Incidence of disseminated Mycobacterium avium-complex infection in HIV patients receiving antiretroviral therapy with use of Mycobacterium avium-complex prophylaxis

2017 ◽  
Vol 28 (14) ◽  
pp. 1426-1432 ◽  
Author(s):  
Younghee Jung ◽  
Kyoung-Ho Song ◽  
Pyoeng Gyun Choe ◽  
Wan Beom Park ◽  
Ji Hwan Bang ◽  
...  
Keyword(s):  
Antiretroviral Therapy ◽  
Cell Count ◽  
Mycobacterium Avium ◽  
Mycobacterium Avium Complex ◽  
Primary Prophylaxis ◽  
Hiv Patients ◽  
Cd4 Cell Count ◽  
Total Observation ◽  
Cd4 Cell ◽  
Current Guidelines

The incidence of disseminated Mycobacterium avium complex (MAC) infection in HIV patients has fallen markedly since the introduction of effective antiretroviral therapy (ART). However, current guidelines still recommend primary prophylaxis. We conducted a retrospective cohort study in a university-affiliated hospital from January 1998 to January 2014. During that period, HIV patients who had at least one CD4 cell count below 50 cells/mm3 and had been treated with ART were enrolled. We compared incidence of disseminated MAC infection in the 12 months after the first CD4 cell count below 50 cells/mm3 between prophylaxis and nonprophylaxis groups. A total of 157 patients were enrolled and the total observation period was 144 patient-years (PY). Thirty-three patients (21%) received primary MAC prophylaxis. The initial CD4 cell count of the prophylaxis group was lower than that of the nonprophylaxis group ( P = 0.024), but the proportion of patients who reached a CD4 cell count >100 cells/mm3 ( P = 0.234) and were virologically suppressed ( P = 0.513) 12 months after ART commencement was not different in the prophylaxis and nonprophylaxis groups. The incidence of MAC did not differ significantly between the groups (3.4/100 PY versus 0.8/100 PY, P = 0.368). Routine MAC prophylaxis may be not required in the era of effective ART.

Occurrence of the IS 900 gene in Mycobacterium avium complex derived from HIV patients

1999 ◽  
Vol 13 (5) ◽  
pp. 367-372 ◽  
Author(s):  
S.A Naser ◽  
J Felix ◽  
H Liping ◽  
C Romero ◽  
N Naser ◽  
...  
Keyword(s):  
Mycobacterium Avium ◽  
Mycobacterium Avium Complex ◽  
Hiv Patients

Polymicrobial Intracerebral Abscess Growing Achromobacter Xylosoxidans and Mycobacterium Avium Complex

2020 ◽  
Author(s):  
Juliana Rotter ◽  
Christopher S. Graffeo ◽  
Hannah E. Gilder ◽  
Lucas P. Carlstrom ◽  
Avital Perry ◽  
...  
Keyword(s):  
Mycobacterium Avium ◽  
Mycobacterium Avium Complex ◽  
Achromobacter Xylosoxidans ◽  
Intracerebral Abscess
Sign in / Sign up

Export Citation Format

Share Document